Published in J Virol on October 01, 1993
Genetic analysis of the major homology region of the Rous sarcoma virus Gag protein. J Virol (1995) 2.76
Requirements for budding of paramyxovirus simian virus 5 virus-like particles. J Virol (2002) 2.02
An N-terminal domain of the Sendai paramyxovirus P protein acts as a chaperone for the NP protein during the nascent chain assembly step of genome replication. J Virol (1995) 1.98
Functional mapping of the nucleoprotein of Ebola virus. J Virol (2006) 1.69
Ultrastructural organization of recombinant Marburg virus nucleoprotein: comparison with Marburg virus inclusions. J Virol (2000) 1.55
Cell entry by measles virus: long hybrid receptors uncouple binding from membrane fusion. J Virol (1996) 1.51
Paramyxovirus assembly and budding: building particles that transmit infections. Int J Biochem Cell Biol (2010) 1.44
Nucleocapsid incorporation into parainfluenza virus is regulated by specific interaction with matrix protein. J Virol (2001) 1.30
Measles virus phosphoprotein gene products: conformational flexibility of the P/V protein amino-terminal domain and C protein infectivity factor function. J Virol (2004) 1.21
The intrinsically disordered C-terminal domain of the measles virus nucleoprotein interacts with the C-terminal domain of the phosphoprotein via two distinct sites and remains predominantly unfolded. Protein Sci (2005) 1.20
Mumps virus matrix, fusion, and nucleocapsid proteins cooperate for efficient production of virus-like particles. J Virol (2009) 1.17
Inducible expression of the P, V, and NP genes of the paramyxovirus simian virus 5 in cell lines and an examination of NP-P and NP-V interactions. J Virol (1995) 1.15
Mapping of the VP40-binding regions of the nucleoprotein of Ebola virus. J Virol (2007) 1.14
Measles virus (MV) nucleoprotein binds to a novel cell surface receptor distinct from FcgammaRII via its C-terminal domain: role in MV-induced immunosuppression. J Virol (2003) 1.10
Long-term replication of Sendai virus defective interfering particle nucleocapsids in stable helper cell lines. J Virol (1994) 1.02
Newcastle disease virus (NDV) marker vaccine: an immunodominant epitope on the nucleoprotein gene of NDV can be deleted or replaced by a foreign epitope. J Virol (2002) 1.00
Ribosomal frameshifting during translation of measles virus P protein mRNA is capable of directing synthesis of a unique protein. J Virol (1995) 0.98
De novo synthesis of N and P proteins as a key step in Sendai virus gene expression. J Virol (2007) 0.91
The C-terminal end of parainfluenza virus 5 NP protein is important for virus-like particle production and M-NP protein interaction. J Virol (2010) 0.90
The measles virus nucleocapsid protein tail domain is dispensable for viral polymerase recruitment and activity. J Biol Chem (2013) 0.85
Purification and characterization of Nipah virus nucleocapsid protein produced in insect cells. J Clin Microbiol (2005) 0.83
Surface expression of the hRSV nucleoprotein impairs immunological synapse formation with T cells. Proc Natl Acad Sci U S A (2014) 0.79
An amino-terminal domain of the Sendai virus nucleocapsid protein is required for template function in viral RNA synthesis. J Virol (1997) 0.78
Nucleocytoplasmic transport of nucleocapsid proteins of enveloped RNA viruses. Front Microbiol (2015) 0.77
Newly identified minor phosphorylation site threonine-279 of measles virus nucleoprotein is a prerequisite for nucleocapsid formation. J Virol (2013) 0.76
Modulation of Re-initiation of Measles Virus Transcription at Intergenic Regions by PXD to NTAIL Binding Strength. PLoS Pathog (2016) 0.75
Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene (1989) 60.30
Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci U S A (1986) 32.58
The rapid generation of oligonucleotide-directed mutations at high frequency using phosphorothioate-modified DNA. Nucleic Acids Res (1985) 12.11
Replication and amplification of defective interfering particle RNAs of vesicular stomatitis virus in cells expressing viral proteins from vectors containing cloned cDNAs. J Virol (1990) 3.93
Sequence of 3,687 nucleotides from the 3' end of Sendai virus genome RNA and the predicted amino acid sequences of viral NP, P and C proteins. Nucleic Acids Res (1983) 3.62
N protein of vesicular stomatitis virus selectively encapsidates leader RNA in vitro. Cell (1983) 3.46
Complexes of Sendai virus NP-P and P-L proteins are required for defective interfering particle genome replication in vitro. J Virol (1992) 2.73
Nucleocapsid protein subunits of simian virus 5, Newcastle disease virus, and Sendai virus. J Virol (1970) 2.58
Transcriptive complex of Newcastle disease virus. I. Both L and P proteins are required to constitute an active complex. Virology (1983) 2.53
Protein-protein interactions within paramyxoviruses identified by native disulfide bonding or reversible chemical cross-linking. J Virol (1980) 2.40
Complex formation with vesicular stomatitis virus phosphoprotein NS prevents binding of nucleocapsid protein N to nonspecific RNA. J Virol (1988) 1.91
the relationship of conformational changes in the Sendai virus nucleocapsid to proteolytic cleavage of the NP polypeptide. Virology (1981) 1.85
Measles virus phosphoprotein retains the nucleocapsid protein in the cytoplasm. Virology (1991) 1.77
Assembly of nucleocapsidlike structures in animal cells infected with a vaccinia virus recombinant encoding the measles virus nucleoprotein. J Virol (1991) 1.73
Isolation and structure of the nucleocapsid of HVJ. Virology (1968) 1.62
The hypervariable C-terminal tail of the Sendai paramyxovirus nucleocapsid protein is required for template function but not for RNA encapsidation. J Virol (1993) 1.61
Assembly of influenza ribonucleoprotein in vitro using recombinant nucleoprotein. Virology (1987) 1.56
Sendai virion transcriptase complex: polyeptide composition and inhibition by virion envelope proteins. J Virol (1974) 1.45
Sendai virus protein-protein interactions studied by a protein-blotting protein-overlay technique: mapping of domains on NP protein required for binding to P protein. J Virol (1991) 1.35
Separate domains of Sendai virus P protein are required for binding to viral nucleocapsids. Virology (1990) 1.24
Complete sequence of the Sendai virus NP gene from a cloned insert. Virology (1984) 1.15
Nucleotide sequence analyses of the genes encoding the HN, M, NP, P, and L proteins of two host range mutants of Sendai virus. Virology (1990) 1.04
Sendai virus NP gene codes for a 524 amino acid NP protein. Virus Genes (1991) 0.97
Expression of rabies virus glycoprotein from a recombinant vaccinia virus. Nature (1984) 3.32
One hundred base pairs of 5' flanking sequence of a vaccinia virus late gene are sufficient to temporally regulate late transcription. Proc Natl Acad Sci U S A (1985) 3.23
A matrix-less measles virus is infectious and elicits extensive cell fusion: consequences for propagation in the brain. EMBO J (1998) 2.48
Yeast mutants pleiotropically impaired in the regulation of the two glutamate dehydrogenases. Biochem Biophys Res Commun (1973) 2.37
Ammonia assimilation in Saccharomyces cerevisiae as mediated by the two glutamate dehydrogenases. Evidence for the gdhA locus being a structural gene for the NADP-dependent glutamate dehydrogenase. Mol Gen Genet (1974) 2.02
Physical mapping of vaccinia virus temperature-sensitive mutations. Virology (1983) 2.00
Ureidosuccinic acid uptake in yeast and some aspects of its regulation. J Bacteriol (1972) 1.98
Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells. J Immunol (1999) 1.92
Host range deletion mutant of vaccinia virus defective in human cells. Virology (1981) 1.81
Ribosomal proteins. Protein compositions of biosynthetic precursors and artifical subparticles from ribosomal subunits in Escherichia coli K 12. Eur J Biochem (1971) 1.77
Assembly of nucleocapsidlike structures in animal cells infected with a vaccinia virus recombinant encoding the measles virus nucleoprotein. J Virol (1991) 1.73
A specific inhibitor of cysteine proteases impairs a Vif-dependent modification of human immunodeficiency virus type 1 Env protein. J Virol (1991) 1.72
Localization and sequence of a vaccinia virus gene required for multiplication in human cells. Proc Natl Acad Sci U S A (1986) 1.62
Ribosomal proteins. 43. In vivo assembly of Escherichia coli ribosomal proteins. J Mol Biol (1973) 1.56
Restricted replication of ectromelia virus in cell culture correlates with mutations in virus-encoded host range gene. Virology (1992) 1.56
Purification, renaturation, and reconstituted protein kinase activity of the Sendai virus large (L) protein: L protein phosphorylates the NP and P proteins in vitro. J Virol (1990) 1.46
Complementation and genetic linkage between vaccinia virus temperature-sensitive mutants. Virology (1982) 1.45
Construction of vaccinia virus recombinants expressing several measles virus proteins and analysis of their efficacy in vaccination of mice. J Gen Virol (1992) 1.44
Protection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either the hemagglutinin or the fusion protein. Proc Natl Acad Sci U S A (1988) 1.43
Sendai virus protein-protein interactions studied by a protein-blotting protein-overlay technique: mapping of domains on NP protein required for binding to P protein. J Virol (1991) 1.35
A cowpox virus gene required for multiplication in Chinese hamster ovary cells. J Virol (1988) 1.31
Fiberless recombinant adenoviruses: virus maturation and infectivity in the absence of fiber. J Virol (1999) 1.28
Sendai virus infection induces apoptosis through activation of caspase-8 (FLICE) and caspase-3 (CPP32). J Virol (1999) 1.27
Role of B cell receptor Ig alpha and Ig beta subunits in MHC class II-restricted antigen presentation. Immunity (1995) 1.25
Sendai virus gene expression in lytically and persistently infected cells. Virology (1990) 1.24
Host range restriction of vaccinia virus in Chinese hamster ovary cells: relationship to shutoff of protein synthesis. J Virol (1978) 1.17
The carboxy-terminal domain of Sendai virus nucleocapsid protein is involved in complex formation between phosphoprotein and nucleocapsid-like particles. Virology (1994) 1.17
Vaccinia virus-related events and phenotypic changes after infection of dendritic cells derived from human monocytes. Virology (2000) 1.16
The assembly of the measles virus nucleoprotein into nucleocapsid-like particles is modulated by the phosphoprotein. Virology (1997) 1.15
Mapping of a vaccinia host range sequence by insertion into the viral thymidine kinase gene. J Virol (1985) 1.06
Detection of a protein encoded by the vaccinia virus C7L open reading frame and study of its effect on virus multiplication in different cell lines. J Gen Virol (1993) 1.04
Long-term replication of Sendai virus defective interfering particle nucleocapsids in stable helper cell lines. J Virol (1994) 1.02
Sendai virus-like particles devoid of haemagglutinin-neuraminidase protein infect cells via the human asialoglycoprotein receptor. J Gen Virol (1998) 0.99
Vaccination of mice against canine distemper virus-induced encephalitis with vaccinia virus recombinants encoding measles or canine distemper virus antigens. Vaccine (1993) 0.98
Sendai virus NP gene codes for a 524 amino acid NP protein. Virus Genes (1991) 0.97
Evidence of measles virus RNA in otosclerotic tissue. ORL J Otorhinolaryngol Relat Spec (1994) 0.96
A tyrosine-based signal present in Ig alpha mediates B cell receptor constitutive internalization. J Immunol (1998) 0.96
Sendai virus efficiently infects cells via the asialoglycoprotein receptor and requires the presence of cleaved F0 precursor proteins for this alternative route of cell entry. J Virol (1997) 0.95
Similar genetic organization between a region of fowlpox virus DNA and the vaccinia virus HindIII J fragment despite divergent location of the thymidine kinase gene. Virology (1987) 0.95
Intracellular pathway for the generation of functional MHC class II peptide complexes in immature human dendritic cells. J Immunol (1998) 0.95
Active gamma-carboxylated human factor IX expressed using recombinant DNA techniques. Nature (1985) 0.95
Rapid and efficient recovery of Sendai virus from cDNA: factors influencing recombinant virus rescue. J Virol Methods (1998) 0.94
The replicative complex of paramyxoviruses: structure and function. Adv Virus Res (1998) 0.94
Localization of viral protein X in simian immunodeficiency virus macaque strain and analysis of its packaging requirements. J Gen Virol (1994) 0.93
The influence of imperfectly paired helices I and III on the catalytic activity of hammerhead ribozymes. Nucleic Acids Res (1994) 0.93
Inefficient measles virus budding in murine L.CD46 fibroblasts. Virology (1999) 0.92
Fowlpox virus recombinant encoding the measles virus fusion protein: protection of mice against fatal measles encephalitis. Vaccine (1990) 0.92
Rapid sequencing of the Sendai virus 6.8 kb large (L) gene through primer walking with an automated DNA sequencer. J Virol Methods (1992) 0.92
Schnitzler syndrome: heterogeneous immunopathological findings involving IgM-skin interactions. Br J Dermatol (2000) 0.91
Localization of a new neutralizing epitope on the mumps virus hemagglutinin-neuraminidase protein. Virus Res (2001) 0.91
The vaccinia virus J5L open reading frame encodes a polypeptide expressed late during infection and required for viral multiplication. Virus Res (1995) 0.90
Respiratory syncytial virus nucleocapsid protein (N) expressed in insect cells forms nucleocapsid-like structures. Virus Res (1994) 0.89
Construction of fowlpox virus vectors with intergenic insertions: expression of the beta-galactosidase gene and the measles virus fusion gene. J Virol (1990) 0.89
Lifelong persistence of paramyxovirus Sendai-6/94 in C129 mice: detection of a latent viral RNA by hybridization with a cloned genomic cDNA probe. Virology (1984) 0.87
Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines. Virology (1996) 0.86
Search for Sendai 6/94 viral RNA in the antigen-free cell line Cl-C-2 isolated from human multiple sclerosis brain tissue. Infect Immun (1983) 0.86
A functional measles virus replication and transcription machinery encoded by the vaccinia virus genome. J Virol Methods (1999) 0.86
Macrophage-derived chemokine gene transfer results in tumor regression in murine lung carcinoma model through efficient induction of antitumor immunity. Gene Ther (2002) 0.85
Alpha IIb beta 3 integrin dissociation induced by EDTA results in morphological changes of the platelet surface-connected canalicular system with differential location of the two separate subunits. J Cell Biol (1993) 0.85
Soluble CD16/Fc gamma RIII induces maturation of dendritic cells and production of several cytokines including IL-12. Adv Exp Med Biol (1997) 0.85
A temperature-sensitive mutant of vaccinia virus defective in an early stage of morphogenesis. Virology (1977) 0.85
In vitro and in vivo study of the ectromelia virus homolog of the vaccinia virus K1L host range gene. Virology (1993) 0.84
Pseudotype formation of Moloney murine leukemia virus with Sendai virus glycoprotein F. J Virol (1998) 0.83
Appearance of the bona fide spiral tubule of ORF virus is dependent on an intact 10-kilodalton viral protein. J Virol (2004) 0.83
Characterization and quality control of recombinant adenovirus vectors for gene therapy. J Chromatogr B Biomed Sci Appl (2001) 0.83
Citrate synthaseless glutamic acid auxotroph of Saccharomyces cerevisiae. Mol Gen Genet (1975) 0.83
Evidence for an alkaline protease in vaccinia virus. Virology (1979) 0.82
Measles virus and otosclerosis. Adv Otorhinolaryngol (2007) 0.81
Transient rescue of Sendai-6/94 cl virus from the persistently infected cell line Cl-E-8 by cocultivation. Virology (1983) 0.81
Simple method for rapid and highly sensitive detection of antiviral-antibodies in serum and cerebrospinal fluid of small laboratory animals. J Virol Methods (1988) 0.80
A vaccinia virus transfer vector using a GUS reporter gene inserted into the I4L locus. Gene (1996) 0.80
Cell killing by frog virus 3: evidence for cell killing by single viral particles or single viral subunits. Biochem Biophys Res Commun (1977) 0.80
Recombinant MUC 1 vaccinia virus: a potential vector for immunotherapy of breast cancer. Cell Mol Biol (Noisy-le-grand) (1994) 0.79
Antibodies directed against a synthetic peptide enable detection of a protein encoded by a vaccinia virus host range gene that is conserved within the Orthopoxvirus genus. J Virol (1989) 0.79
Selective protection of in vitro synthesized cDNA against nucleases by incorporation of phosphorothioate-analogues. Nucleic Acids Res (1985) 0.78
Embedding in Spurr's resin is a good choice for immunolabelling after freeze drying as shown with chemically unfixed dendritic cells. J Microsc (2002) 0.77